| LncRNA-SNHG16 predicts poor prognosis and promotes tumor proliferation through epigenetically silencing p21 in bladder cancer |
25 |
| LncRNA SNHG14 promotes inflammatory response induced by cerebral ischemia/reperfusion injury through regulating miR-136-5p/ROCK1 |
23 |
| miR-200c inhibits TGF-beta-induced-EMT to restore trastuzumab sensitivity by targeting ZEB1 and ZEB2 in gastric cancer |
18 |
| miR-140-5p inhibits the proliferation and enhances the efficacy of doxorubicin to breast cancer stem cells by targeting Wnt1 |
15 |
| Regulated intratumoral expression of IL-12 using a RheoSwitch Therapeutic System (R) (RTS (R)) gene switch as gene therapy for the treatment of glioma |
15 |
| Long non-coding RNA DLEU1 predicts poor prognosis of gastric cancer and contributes to cell proliferation by epigenetically suppressing KLF2 |
14 |
| Serum exosomes contain ECRG4 mRNA that suppresses tumor growth via inhibition of genes involved in inflammation, cell proliferation, and angiogenesis |
14 |
| Inhibition of microRNA-384-5p alleviates osteoarthritis through its effects on inhibiting apoptosis of cartilage cells via the NF-kappa B signaling pathway by targeting SOX9 |
13 |
| Inducible Caspase9-mediated suicide gene for MSC-based cancer gene therapy |
11 |
| CRISPR/Cas9 genome editing technology significantly accelerated herpes simplex virus research |
11 |
| Genomic landscape and prognostic analysis of mantle cell lymphoma |
11 |
| c-Myc induced upregulation of long non-coding RNA SNHG16 enhances progression and carcinogenesis in oral squamous cell carcinoma |
10 |
| Dissecting the functional role of microRNA 21 in osteosarcoma |
10 |
| Let-7b attenuates cisplatin resistance and tumor growth in gastric cancer by targeting AURKB |
9 |
| Enhanced expressions of FHL2 and iASPP predict poor prognosis in acute myeloid leukemia |
9 |
| JAK/STAT inhibition with ruxolitinib enhances oncolytic virotherapy in non-small cell lung cancer models |
9 |
| Upregulating microRNA-498 inhibits gastric cancer proliferation invasion and chemoresistance through inverse interaction of Bmi1 |
8 |
| Development of an adenovirus vector vaccine platform for targeting dendritic cells |
8 |
| Arming oncolytic reovirus with GM-CSF gene to enhance immunity |
8 |
| Prognostic role of DOK family adapters in acute myeloid leukemia |
8 |
| T-bet promotes potent antitumor activity of CD4(+) CAR T cells |
8 |
| Turning cold tumours hot: oncolytic virotherapy gets up close and personal with other therapeutics at the 11th Oncolytic Virus Conference |
7 |
| miR-182 regulates trastuzumab resistance by targeting MET in breast cancer cells |
7 |
| MicroRNA21 and the various types of myeloid leukemia |
6 |
| MicroRNA-122 negatively associates with peroxiredoxin-II expression in human gefitinib-resistant lung cancer stem cells |
6 |
| GINS2 promotes cell proliferation and inhibits cell apoptosis in thyroid cancer by regulating CITED2 and LOXL2 |
5 |
| Inhibitor of growth 3 induces cell death by regulating cell proliferation, apoptosis and cell cycle arrest by blocking the PI3K/AKT pathway |
5 |
| Upregulation of microRNA-3129 suppresses epithelial ovarian cancer through CD44 |
5 |
| Netrin-1 elicits metastatic potential of non-small cell lung carcinoma cell by enhancing cell invasion, migration and vasculogenic mimicry via EMT induction |
5 |
| LncRNA SPRY4-IT was concerned with the poor prognosis and contributed to the progression of thyroid cancer |
5 |
| Quantification and functional evaluation of CD40L production from the adenovirus vector ONCOS-401 |
5 |
| ERCC6L that is up-regulated in high grade of renal cell carcinoma enhances cell viability in vitro and promotes tumor growth in vivo potentially through modulating MAPK signalling pathway |
5 |
| Intratumoral IFN-alpha gene delivery reduces tumor-infiltrating regulatory T cells through the downregulation of tumor CCL17 expression |
5 |
| High expression of UBE2T predicts poor prognosis and survival in multiple myeloma |
5 |
| Down-regulated long non-coding RNA RNAZFHX4-AS1 suppresses invasion and migration of breast cancer cells via FAT4-dependent Hippo signaling pathway |
5 |
| Complex consisting of antisense DNA and beta-glucan promotes internalization into cell through Dectin-1 and hybridizes with target mRNA in cytosol |
4 |
| Gene therapy for castration-resistant prostate cancer cells using JC polyomavirus-like particles packaged with a PSA promoter driven-suicide gene |
4 |
| Clinical and biological implications of mutational spectrum in acute myeloid leukemia of FAB subtypes M4 and M5 |
4 |
| Gene expression profiles reveal key genes for early diagnosis and treatment of adamantinomatous craniopharyngioma |
4 |
| High expression levels of SMAD3 and SMAD7 at diagnosis predict poor prognosis in acute myeloid leukemia patients undergoing chemotherapy |
3 |
| Inhibition of oncogenic cap-dependent translation by 4EGI-1 reduces growth, enhances chemosensitivity and alters genome-wide translation in non-small cell lung cancer |
3 |
| Adenovirus-mediated transfer of HPV 16 E6/E7 antisense RNA combined with cisplatin inhibits cellular growth and induces apoptosis in HPV-positive head and neck cancer cells |
3 |
| Silencing SATB1 overcomes temozolomide resistance by downregulating MGMT expression and upregulating SLC22A18 expression in human glioblastoma cells |
3 |
| Downregulation of miR-152 contributes to DNMT1-mediated silencing of SOCS3/SHP-1 in non-Hodgkin lymphoma |
3 |
| Six-transmembrane epithelial antigen of the prostate 1 protects against increased oxidative stress via a nuclear erythroid 2-related factor pathway in colorectal cancer |
3 |
| Endostatin gene therapy delivered by attenuated Salmonella typhimurium in murine tumor models |
3 |
| Clinical characteristics and prognostic analysis of multiple primary malignant neoplasms in patients with lung cancer |
2 |
| Efficient tumor transduction and antitumor efficacy in experimental human osteosarcoma using retroviral replicating vectors |
2 |
| Schwannoma gene therapy by adeno-associated virus delivery of the pore-forming protein Gasdermin-D |
2 |
| Synergistic antitumour effects of rapamycin and oncolytic reovirus |
2 |
